| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| 5AM Ventures V, L.P. | 11% | $25,485,387 | 4,123,849 | Kush Parmar | 14 Nov 2025 | |||
| ROCHE FINANCE LTD | 6.9% | $23,019,270 | 2,569,115 | Roche Finance Ltd | 31 Dec 2024 | |||
| BlackRock, Inc. | 5.3% | $17,691,090 | 1,974,452 | BlackRock, Inc. | 31 Dec 2024 | |||
| TCG Crossover GP I, LLC | 5% | $11,849,186 | 1,917,344 | TCG Crossover GP I, LLC | 19 Nov 2025 | |||
| JANUS HENDERSON GROUP PLC | 4% | -27% | $9,964,391 | -$3,932,443 | 1,521,281 | -28% | JANUS HENDERSON GROUP PLC | 30 Jun 2025 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.9% | -84% | $2,091,051 | -$12,800,322 | 360,526 | -86% | T. Rowe Price Associates, Inc. | 30 Sep 2025 |
As of 31 Dec 2025, 111 institutional investors reported holding 24,407,232 shares of Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA). This represents 64% of the company’s total 38,346,880 outstanding shares.
The largest institutional shareholders of Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA) together control 58% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 13% | 5,072,730 | +4.3% | 0.31% | $52,147,664 |
| 5AM Venture Management, LLC | 11% | 4,056,379 | -4.7% | 13% | $41,699,576 |
| BlackRock, Inc. | 5.6% | 2,147,260 | +5% | 0% | $22,073,833 |
| TCG Crossover Management, LLC | 5.4% | 2,088,392 | +257% | 0.71% | $21,468,670 |
| VANGUARD GROUP INC | 4.3% | 1,632,460 | +1.8% | 0% | $16,781,689 |
| WELLINGTON MANAGEMENT GROUP LLP | 2.7% | 1,044,758 | +9.5% | 0% | $10,740,113 |
| StepStone Group LP | 2% | 761,277 | 0% | 4.5% | $7,825,928 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.7% | 639,947 | -0.8% | 0% | $6,580,002 |
| STATE STREET CORP | 1.3% | 508,789 | +2% | 0% | $5,230,351 |
| MILLENNIUM MANAGEMENT LLC | 1.3% | 497,695 | -41% | 0% | $5,116,305 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.95% | 362,786 | +15% | 0.01% | $3,729,440 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.85% | 327,423 | -9.2% | 0% | $3,367,000 |
| ACADIAN ASSET MANAGEMENT LLC | 0.81% | 310,833 | +4.3% | 0.01% | $3,193,000 |
| CITADEL ADVISORS LLC | 0.76% | 292,770 | -13% | 0% | $3,009,676 |
| DIMENSIONAL FUND ADVISORS LP | 0.71% | 273,378 | -31% | 0% | $2,809,666 |
| MORGAN STANLEY | 0.68% | 260,251 | -25% | 0% | $2,675,384 |
| RENAISSANCE TECHNOLOGIES LLC | 0.66% | 252,635 | -57% | 0% | $2,597,088 |
| ROYCE & ASSOCIATES LP | 0.64% | 247,147 | -28% | 0.03% | $2,540,671 |
| NORTHERN TRUST CORP | 0.59% | 226,301 | -11% | 0% | $2,326,375 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.58% | 221,269 | +19% | 0% | $2,274,645 |
| GOLDMAN SACHS GROUP INC | 0.54% | 205,173 | -7.7% | 0% | $2,109,181 |
| BNP PARIBAS FINANCIAL MARKETS | 0.47% | 180,969 | 0% | 0% | $1,860,361 |
| Qube Research & Technologies Ltd | 0.46% | 176,018 | -39% | 0% | $1,809,465 |
| Woodline Partners LP | 0.37% | 142,110 | 0.01% | $1,460,891 | |
| ALGERT GLOBAL LLC | 0.34% | 128,611 | -0.93% | 0.02% | $1,322,000 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 24,407,232 | $250,738,606 | +$6,140,638 | $10.28 | 111 |
| 2025 Q3 | 28,408,651 | $164,766,270 | -$9,410,304 | $5.80 | 114 |
| 2025 Q2 | 29,583,750 | $198,790,015 | -$4,881,409 | $6.72 | 105 |
| 2025 Q1 | 30,241,830 | $274,509,238 | -$4,478,805 | $9.04 | 110 |
| 2024 Q4 | 30,637,008 | $529,755,566 | +$9,629,460 | $17.29 | 102 |
| 2024 Q3 | 30,099,996 | $481,057,545 | +$6,089,620 | $15.98 | 97 |
| 2024 Q2 | 29,668,185 | $422,803,373 | +$52,052,901 | $14.25 | 82 |
| 2024 Q1 | 26,027,444 | $368,797,900 | -$3,772,264 | $14.17 | 76 |
| 2023 Q4 | 26,281,861 | $396,641,035 | +$3,492,844 | $15.09 | 62 |
| 2023 Q3 | 26,035,608 | $411,375,608 | +$4,515,692 | $15.80 | 55 |
| 2023 Q2 | 25,751,810 | $389,877,766 | +$13,317,282 | $15.14 | 56 |
| 2023 Q1 | 24,900,040 | $361,043,649 | +$2,708,627 | $14.50 | 53 |
| 2022 Q4 | 24,715,588 | $334,178,958 | +$2,434,963 | $13.52 | 46 |
| 2022 Q3 | 24,517,008 | $386,369,092 | -$2,728,204 | $15.76 | 33 |
| 2022 Q2 | 24,778,477 | $301,833,417 | -$12,927,920 | $12.18 | 35 |
| 2022 Q1 | 25,876,494 | $242,821,140 | +$2,263,033 | $9.39 | 48 |
| 2021 Q4 | 24,861,440 | $425,110,000 | +$413,748,000 | $17.12 | 45 |